Diabetes in Cats: Symptoms, Causes, Treatment & Remission Guide

Introduction

Diabetes mellitus is a common, highly treatable condition that affects roughly 1 in 100 cats, and early treatment can dramatically improve outcomes. Diabetes mellitus (often shortened to "diabetes" or "DM") is a syndrome of persistent high blood sugar caused by an absolute or relative deficiency of insulin, a hormone that moves glucose from the blood into the body's cells ^{[1, 2, 3]}. When insulin is missing or does not work properly, glucose builds up in the bloodstream, disrupting how the body handles carbohydrates, fats and proteins ^{[1, 3]}.

Insulin is made by special cells in the pancreas called beta cells. Without enough functioning insulin, glucose cannot enter cells efficiently, blood glucose rises, and the classic signs of diabetes appear ^{[4, 5]}. Feline DM is one of the most common endocrine diseases seen in veterinary practice, and its prevalence appears to be increasing as more cats live indoors and struggle with obesity ^{[1, 6, 3]}.

Most diabetic cats have a disease very similar to human type 2 diabetes: the body still makes some insulin, but the tissues resist its action, and the beta cells gradually wear out ^{[6, 3, 5]}. Prompt diagnosis and treatment can prevent dangerous complications such as severe weight loss and a life-threatening condition called diabetic ketoacidosis, and they significantly improve the chance of diabetic remission (when a cat no longer needs insulin) ^{[6, 3]}. This guide explains the symptoms, causes, types, diagnosis, treatment, nutrition, complications and day-to-day care your cat needs.

Symptoms and Signs of Diabetes in Cats

The classic warning signs are drinking more, urinating more, and losing weight despite a good appetite. Increased thirst (polydipsia) and increased urination (polyuria), together known as PU/PD, are usually the first clues owners notice ^{[3, 2, 1]}. Many cats also develop a ravenous appetite early in the disease because glucose cannot enter cells to satisfy hunger ^{[3, 1]}.

The classic presentation of diabetes mellitus in cats is polyphagia (increased appetite) with concurrent weight loss, and most diabetic cats are polyphagic at diagnosis. However, a notable minority of cats—particularly those with concurrent illness (e.g., pancreatitis, CKD) or those developing diabetic ketoacidosis (DKA)—may present with decreased appetite or anorexia. Owners and clinicians should be aware that inappetence in a diabetic cat is a red flag warranting urgent evaluation for DKA or concurrent disease, but it is not the typical presenting sign. Unexplained weight loss despite eating well is a hallmark sign of uncomplicated diabetes ^{[3, 2, 1]}. Many cats also become lethargic, lose muscle mass along the spine and hindquarters, and develop a dull, oily or dandruff-prone coat ^{[3, 2, 1]}.

A characteristic but less common sign is the "plantigrade stance," where the cat walks with its hocks (ankles) dropped flat to the ground because nerve damage (diabetic neuropathy) has weakened the hind limbs; this is seen in roughly 3–10% of cases depending on the population ^{[3, 2]}. Many cats go through a silent, subclinical phase lasting months in which blood glucose is elevated but stays below the renal threshold (~16 mmol/L; 290 mg/dL), so obvious signs only appear once sugar spills into the urine ^{[7, 8]}. Diabetic ketoacidosis (DKA) presents as an emergency with vomiting, severe lethargy, dehydration, and collapse if untreated ^{[3, 2, 1]}. Some cats are diagnosed before classic signs develop, simply because routine wellness bloodwork was performed in an older, overweight cat ^[6]. Finally, common concurrent diseases such as chronic kidney disease (CKD) or pancreatitis can mask typical signs, so a polyphagic cat with diabetes and CKD may not seem unusually hungry ^{[3, 2]}.

Causes and Risk Factors for Diabetes in Cats

Feline diabetes is most often a type 2-like disease driven by insulin resistance combined with progressive damage to the insulin-producing beta cells ^{[9, 7, 5]}. It is multifactorial, meaning multiple overlapping factors usually contribute.

The major risk factors include obesity, physical inactivity, an indoor lifestyle, increasing age (most cases occur in cats over 8 years), being male and neutered, and a possible genetic predisposition (Burmese cats are over-represented in several studies) ^{[9, 1]}. Obesity is the single most important modifiable risk factor: over half of diabetic cats are overweight at diagnosis, and many have been obese in the past ^{[9, 1]}. Losing weight through portion control and increased activity is one of the most powerful things an owner can do.

Inside the pancreas, a process called islet amyloidosis, where a protein called amylin deposits within the insulin-producing islets, progressively damages beta cells and reduces their ability to secrete insulin ^{[7, 8]}. Pancreatitis is also commonly associated with feline diabetes; inflammation may damage beta cells, and there is a debated chicken-and-egg relationship between the two ^{[9, 6, 8]}. Several other hormone disorders, including hypersomatotropism (acromegaly), hyperadrenocorticism (Cushing's) and hyperthyroidism, can cause or worsen diabetes by inducing severe insulin resistance ^{[9, 10, 6]}. Iatrogenic diabetes (caused by medication) can follow high-dose glucocorticoid therapy; one study found DM developed in 9.7% of cats given prednisolone at ≥1.9 mg/kg/day for more than three weeks ^{[1, 3]}. Chronic inflammatory conditions such as stomatitis, inflammatory bowel disease and degenerative joint disease may also contribute to insulin resistance ^[7].

It is important to note that although high-carbohydrate diets can increase insulin demand, there is no definitive clinical trial evidence proving they directly cause diabetes or that low-carbohydrate diets reliably prevent it. Sedentary living and age-related muscle loss (sarcopenia) are also suspected contributors ^{[9, 7]}. Addressing weight and lifestyle factors can delay or even prevent progression from pre-diabetic states to clinical diabetes ^[6].

Types of Diabetes in Cats

The vast majority of diabetic cats have a type 2-like disease; true type 1 (insulin-dependent) diabetes is extremely rare in this species ^{[1, 6, 5, 8]}. In type 2-like disease, the pancreas can still produce insulin, but the body becomes resistant to it and beta cells gradually fail.

Type 1 diabetes results from immune-mediated destruction of beta cells and absolute insulin deficiency, but this is essentially unheard of in cats ^{[1, 8]}. Type 3 diabetes, also called "specific types of diabetes due to other causes," is triggered by an identifiable disease or drug that causes insulin resistance or beta-cell damage, examples include pancreatitis, acromegaly, hyperadrenocorticism, and medications such as glucocorticoids or progestogens ^{[9, 6]}. Clinically, veterinarians also stage diabetes as uncomplicated (stable), diabetic ketoacidosis (DKA, a life-threatening emergency), or the very rare hyperosmolar hyperglycemic syndrome.

Diabetic remission is defined by the international ALIVE (Agreeing Language in Veterinary Endocrinology) project as maintaining normal blood sugar for at least 4 weeks without insulin or other glucose-lowering drugs, reflecting partial recovery of beta-cell function ^{[3, 10]}. Remission is achievable in a subset of cats, especially when intensive insulin and low-carbohydrate dietary management is started early, but 13–40% of cats in remission will eventually relapse ^{[3, 10, 2]}. Cats with DKA always require hospitalization and insulin therapy, whereas clinically stable cats may be managed with either insulin injections or newer oral medications ^{[6, 3]}.

How Vets Diagnose Diabetes in Cats

Diagnosis is based on three findings: persistent high blood glucose, glucose in the urine, and compatible clinical signs, using the standardized ALIVE criteria ^{[1, 8, 3, 2]}. Most diabetic cats show a fasting blood glucose above 15–16 mmol/L (270–290 mg/dL) or a random glucose above ~11 mmol/L (~200 mg/dL); the renal threshold for glucose is approximately 16 mmol/L ^{[8, 3]}.

One of the trickiest challenges is stress hyperglycemia, a temporary spike caused by the adrenaline of a vet visit. Stress hyperglycemia can be of any magnitude and mimic true diabetes, so repeat testing, home monitoring or additional biomarkers such as serum fructosamine are used to confirm chronic hyperglycemia ^{[6, 3, 2]}. Serum fructosamine reflects average blood glucose over the preceding 2–3 weeks and is the single most useful test to distinguish a stressed cat from a genuinely diabetic one ^{[1, 11]}. A urinalysis will show glucosuria, and the presence of ketones (ketonuria or ketonemia) signals ketosis, which warrants immediate concern ^{[1, 8]}.

Every newly diagnosed diabetic cat should have a minimum database including a complete blood count (CBC), serum biochemistry and electrolytes to assess dehydration, electrolyte loss and common concurrent diseases such as CKD, pancreatitis and hepatic lipidosis ^{[1, 8]}. Screening for underlying endocrinopathies (acromegaly via IGF-1, hyperthyroidism, hyperadrenocorticism) is advised when insulin resistance is suspected or response to therapy is poor ^{[10, 12]}. A urine culture is recommended even when sediment looks inactive because diabetic cats are prone to silent urinary tract infections ^[8]. In ambiguous cases, continuous glucose monitoring (CGM) or home blood glucose curves can confirm persistent hyperglycemia and guide therapy ^{[3, 2]}. Some at-risk cats are caught in a "prediabetic" state with mild hyperglycemia (7–<10 mmol/L; 126–<180 mg/dL), although formal diagnostic criteria do not yet exist; these cats warrant close monitoring ^{[6, 3]}.

Treatment Options for Diabetic Cats

Diabetes is a lifelong but very manageable disease, and many cats can ultimately come off insulin through remission. The goals of treatment are to eliminate clinical signs, avoid dangerous hypoglycemia (low blood sugar) and ketoacidosis, achieve stable glycemic control, and ideally induce diabetic remission ^{[3, 2]}.

Insulin therapy remains the cornerstone for most diabetic cats. Available formulations include protamine zinc insulin (PZI), glargine, detemir and lente insulin, each with different duration and peak profiles ^{[3, 2, 8]}. No single insulin formulation has been proven superior; the choice is individualized based on the cat's response, cost, and the caregiver's experience, with remission as a key goal ^{[3, 2]}. Insulin is given by subcutaneous (under-the-skin) injection, usually twice daily, and the dose is adjusted gradually based on clinical signs, blood glucose curves and fructosamine trends ^{[3, 9]}.

Low-carbohydrate, high-protein dietary therapy is an integral part of treatment, improving glycemic control and significantly increasing the chance of remission ^{[8, 3, 2]}. In overweight cats, controlled weight loss reduces insulin resistance and facilitates remission; body weight should be checked every 2 weeks ^{[6, 1]}. Cats with secondary diabetes also require management of the underlying cause, discontinuing diabetogenic drugs, treating pancreatitis, or addressing acromegaly or Cushing's, alongside glycaemic therapy ^{[12, 3]}. Treatment response is monitored with a combination of clinical sign diaries, in-clinic or home blood glucose curves, and serum fructosamine, with adjustments made gradually to avoid hypoglycemia ^[3].

Diabetic remission is a realistic target for many type 2-like diabetic cats, especially when intensive early management with insulin and a low-carbohydrate diet is pursued ^{[3, 10]}. Owner education on correct insulin handling, injection technique and recognition of hypoglycemia is critical for safe and effective treatment ^{[13, 3, 6]}. A spectrum-of-care approach allows veterinarians to tailor treatment and monitoring intensity to the caregiver's budget and capabilities, improving access and adherence ^[6].

New and Emerging Treatments for Feline Diabetes

A new generation of oral medications called SGLT2 inhibitors now gives stable diabetic cats a needle-free treatment option ^{[4, 3, 2]}. SGLT2 stands for sodium–glucose cotransporter-2; these drugs lower blood glucose by causing the kidneys to excrete excess glucose in the urine, independent of insulin. Two products are FDA-approved in the United States: bexagliflozin (Bexacat) and velagliflozin (Senvelgo) ^{[4, 3, 2]}.

SGLT2 inhibitors are appropriate for clinically stable diabetic cats that are eating well, have no history of DKA, and meet other screening criteria set by the veterinarian ^{[6, 5, 3]}. Close monitoring for ketones is essential, because SGLT2 inhibitors can trigger euglycemic DKA (eDKA), a dangerous form of ketoacidosis in which blood glucose looks normal but ketones are dangerously high ^{[10, 3, 2]}. Owners must regularly check urine or blood ketones using dipsticks or handheld meters, following the schedule their veterinary team provides.

GLP-1 receptor agonists (glucagon-like peptide-1 agonists) such as exenatide and liraglutide potentiate insulin secretion, slow gastric emptying and promote weight loss. Off-label use in cats is being explored, particularly for prediabetes and obesity, but robust clinical data are still lacking ^{[3, 6, 2]}. Continuous glucose monitoring (CGM) devices are increasingly used, providing detailed 24-hour glycemic profiles, reducing clinic stress and enabling more precise treatment modifications ^{[2, 3]}. It has been hypothesized that continuing SGLT2 inhibitors after remission might prevent relapse, but this remains unproven in cats ^{[3, 10]}. Future therapies under investigation target islet amyloidosis and beta-cell regeneration, but no clinically available intervention currently halts or reverses beta-cell loss. Long-term safety, impact on remission rates and survival benefits of SGLT2 inhibitors are still being evaluated ^{[3, 11]}.

Feeding and Nutrition for Diabetic Cats

A low-carbohydrate, high-protein diet is a cornerstone of diabetic management and dramatically increases the chance of remission ^{[3, 2]}. Recommended nutrient targets are less than 25% dry-matter carbohydrate, less than 15% of metabolizable energy from carbohydrates, or fewer than 5 g of carbohydrate per 100 kcal; many prescription and over-the-counter foods meet these goals ^[2].

Canned (wet) foods are preferred over dry kibble because they are typically lower in carbohydrates, higher in protein and moisture, and promote satiety and hydration ^{[8, 1]}. In one study, diabetic cats fed commercial low-carbohydrate wet food were three times more likely to achieve remission than those fed a prescription dry diet ^[6]. For overweight cats, gradual weight loss, typically 0.5–1% of body weight per week under veterinary guidance, reduces insulin resistance; weekly weigh-ins guide caloric adjustments ^{[6, 1]}.

Consistent meal timing matters: two measured meals per day, often offered just before insulin injections, helps match glucose absorption with insulin action and minimizes hypoglycemic risk ^[1]. For underweight cats, ensuring adequate caloric intake is the priority; appetite stimulants such as capromorelin should be avoided in diabetic cats because they can cause hyperglycemia ^{[3, 2]}. During illness or reduced appetite, the diet should not be suddenly changed; instead, veterinary advice should be sought to manage the underlying issue and maintain glycaemic stability ^[2]. Free-choice feeding is generally discouraged in diabetic cats because it leads to unpredictable postprandial glucose fluctuations. The nutritional plan must be individualized, taking into account concurrent conditions such as CKD or pancreatitis and the cat's clinical stage ^{[2, 10]}.

Complications of Feline Diabetes

Hypoglycemia (low blood sugar) is the most common acute complication of insulin therapy and can be life-threatening, presenting as weakness, disorientation, seizures or coma. Always keep glucose syrup or honey on hand to apply to the gums in an emergency, and contact your vet immediately ^[3].

Diabetic ketoacidosis (DKA) is a critical emergency in which the body breaks down fat for fuel and produces ketone bodies, leading to metabolic acidosis, dehydration and electrolyte derangements. Mortality is 26–41% and recurrence 18–42%, so DKA is both dangerous and likely to repeat if not well managed ^{[3, 1, 2]}. Euglycemic DKA (eDKA) can develop in cats treated with SGLT2 inhibitors, where ketosis occurs with only mild or normal blood glucose; this mandates regular home ketone monitoring ^{[10, 3]}.

Diabetic peripheral neuropathy causes the classic plantigrade stance and hindlimb weakness due to prolonged hyperglycaemia; the nerve damage is largely reversible with improved glycaemic control ^{[3, 2, 1]}. Hyperglycaemia also suppresses immunity, predisposing cats to infections, particularly silent urinary tract infections, which is why routine urine cultures are recommended ^[8]. Hepatic lipidosis (fatty liver disease) may develop in diabetic cats that become anorexic, especially during DKA, complicating management and worsening prognosis ^[3]. Common comorbidities such as pancreatitis, CKD, hyperthyroidism and acromegaly frequently accompany diabetes and make glycaemic control more difficult ^[3]. Recurrent DKA episodes are associated with a poor long-term outlook ^{[2, 3]}.

What this means for your cat: Watch for sudden weakness, lethargy, vomiting or loss of appetite; check ketones as instructed if your cat is on an SGLT2 inhibitor; and call your vet immediately if anything changes.

Rebound hyperglycemia (the Somogyi effect), where insulin-induced low blood sugar triggers a counter-regulatory surge, can occur and confuse dose adjustments, although its clinical significance in cats is debated ^[2]. Cataracts, a well-known complication in diabetic dogs and humans, are uncommon in diabetic cats, one study reported lens opacities in only 2.1% of cases, with uncertain causality ^[9].

Prognosis and Life Expectancy for Cats With Diabetes

With appropriate treatment and good owner commitment, many diabetic cats live for years with an excellent quality of life; the disease is manageable but not curable ^[1]. Prognosis varies dramatically by clinical stage: uncomplicated stable diabetes carries a good prognosis, whereas DKA has a guarded outlook with mortality rates of 26–41% and high recurrence ^{[2, 3]}.

Diabetic remission is achievable in a meaningful proportion of cats and is associated with a better long-term outcome, although 13–40% of cats in remission eventually relapse, and a second remission is less likely ^{[3, 10, 2]}. Predictors of remission include a lower blood glucose at diagnosis, prompt initiation of insulin and low-carbohydrate diet, and sustained normal fasting glucose and glucose tolerance after remission ^{[3, 6, 2]}. Cats in remission remain at risk of relapse, particularly if dysglycaemia persists; periodic monitoring of fasting blood glucose or fructosamine is essential ^[6].

Concurrent diseases, notably CKD, pancreatitis, acromegaly or neoplasia, negatively impact survival and may eventually become the primary reason for euthanasia ^{[12, 6]}. Euthanasia rates are significant: approximately 10% at diagnosis and another 10% within the first year, often due to treatment cost, caregiver burden, pet welfare concerns or poor treatment response ^{[5, 6]}. In the UK specifically, 20–30% of newly diagnosed diabetic cats are euthanized within the first year, with around 10% due to owner reluctance to use insulin and a further 10% due to compliance issues, highlighting the critical need for alternative therapies and better owner support ^[5].

Early diagnosis, before the development of weight loss, neuropathy or DKA, improves both survival and quality of life, and increases the chance of inducing remission ^{[6, 3]}. Untreated diabetes is ultimately fatal, but most cats that receive consistent management enjoy a good outcome ^[1]. SGLT2 inhibitors provide an oral, injection-free treatment option that may help reduce early euthanasia in diabetic cats, though their long-term impact on survival is still being studied.

Living With a Diabetic Cat: Daily Management

Daily management relies on a consistent routine: fixed meal times, insulin injections at the same time each day, and regular monitoring of appetite and demeanor ^[1]. Owners must be trained to properly handle insulin, refrigerate it, gently roll (never shake) the vial, draw up doses accurately, administer subcutaneous injections, and dispose of sharps safely.

Home blood glucose monitoring using a glucometer (an ear-prick test) provides real-time data; if the cat tolerates it, full glucose curves can be performed at home. Urine glucose dipsticks are a less accurate but acceptable alternative ^{[1, 3]}. The ALIVE Diabetic Clinical Score (DCS) is a free, standardized tool that allows caregivers to track polyuria, polydipsia, appetite, weight and activity, facilitating early detection of changes and dose adjustments ^{[6, 2]}. A daily log or digital spreadsheet should record diet, water intake, urine output (qualitative), insulin dose, body weight and any unusual behaviors, enabling trend analysis over time ^{[1, 3]}. Weekly weighing at home or regular in-clinic checks help identify weight loss (a red flag for ketosis or poor control) or unwanted weight gain (which may signal over-treatment or undiagnosed acromegaly) ^[3].

For cats on SGLT2 inhibitors, owners must also regularly check urine or blood ketones using dipsticks or handheld meters according to a veterinary plan, and report any inappetence, vomiting or lethargy immediately ^{[10, 3]}. Weight loss in overweight or obese cats is essential to improve outcomes and should be carefully managed, aiming for a maximum loss of 0.5–1% of body weight per week ^[3]. Veterinary rechecks every 3–6 months (more frequently at first) for physical exam, body weight, blood glucose profiles and/or fructosamine are essential ^{[1, 3, 10]}. Open communication with the veterinary team is vital; any change in drinking, urination, appetite or attitude should be reported without delay ^{[13, 6]}. Costs can be reduced by selecting affordable monitoring options, over-the-counter low-carb diets and generic insulin where appropriate, without compromising quality of care ^[6].

What this means for your cat: Ask your vet for a written daily care plan, a home glucose-monitoring demo, and a hypoglycemia emergency kit (glucose syrup or honey, contact numbers).

Quality of Life and When to Consider Euthanasia

Well-managed diabetes allows many cats to live with good energy, normal appetite, stable weight and minimal restrictions; stable diabetic cats often enjoy a high quality of life ^[14]. The ALIVE Diabetic Clinical Score (DCS) is a standardized system that assesses glycaemic control based on owner-reported signs of PU/PD, weight loss, activity level and appetite, giving a useful snapshot of how the cat is doing ^{[6, 3]}. Robust data on the impact of treatment choices on quality of life for the owner and cat are not yet available, so decisions currently rely on owner perception and veterinary guidance ^[6].

Reasons for euthanasia in diabetic cats include severe, unmanageable concurrent disease (e.g., end-stage CKD, neoplasia), repeated DKA episodes, insurmountable financial or caregiver burden, and perceived poor pet welfare ^[6]. When diabetes is treatable, euthanasia at diagnosis should be avoided; a spectrum-of-care framework offers multiple treatment and monitoring levels to match owner capabilities and may prevent early euthanasia ^[6]. When repeated life-threatening complications such as DKA recur despite optimal management, or when advanced comorbidities cause unrelievable suffering, humane euthanasia should be considered ^[6].

The decision should be a collaborative process between the veterinarian and owner, weighing prognosis, the cat's welfare, financial realities and the emotional toll on the family ^[6]. Palliative and hospice care principles can be applied, focusing on comfort, pain relief, stress reduction and nutritional support when cure is no longer possible , ^[3]. Veterinary teams should provide empathetic support, discuss available resources, and help owners navigate grief and decision-making with compassion.

Similar Conditions That Can Look Like Diabetes Mellitus

Several other common feline diseases share the "drink more, pee more, lose weight" pattern, so your vet will rule these out before confirming diabetes. Hyperthyroidism shares polyphagia, weight loss and PU/PD; a thyroid panel (total T4, free T4) distinguishes it, although the two can coexist ^{[1, 10]}. Chronic kidney disease also causes PU/PD and weight loss; blood urea nitrogen, creatinine, and urine specific gravity help differentiate, though many senior cats have both CKD and diabetes ^[3].

Hyperadrenocorticism (Cushing's) leads to polyphagia, PU/PD, coat changes and muscle wasting; diagnosis requires adrenal function tests such as a dexamethasone suppression test or ACTH stimulation test, and it may be complicated by concurrent diabetes ^{[12, 10]}. Acromegaly (hypersomatotropism) can present with diabetes-like signs plus broad facial features, prognathia (a protruding lower jaw) and organomegaly; a markedly elevated IGF-1 and advanced imaging confirm the diagnosis ^[3]. Psychogenic polydipsia is rare in cats, but excessive water intake with low urine specific gravity and normal blood glucose can mimic PU/PD, requiring careful evaluation.

Urinary tract infections can cause polyuria and perineal wetting; urinalysis and culture with absence of glucosuria and hyperglycaemia help exclude diabetes ^[8]. Hepatic lipidosis, often triggered by anorexia, may cause vomiting, weight loss and jaundice that overlap with DKA, and has been associated with DKA in some cats receiving SGLT2 inhibitors; liver enzymes, abdominal ultrasound and absence of persistent hyperglycaemia help differentiate ^[3]. Finally, stress hyperglycaemia can produce a temporary diabetes-like picture; serial blood glucose measurements, fructosamine and home monitoring distinguish it from true diabetes ^{[3, 2]}.

What We Still Don't Know: Gaps and Current Research

Veterinary researchers are actively working to fill several important knowledge gaps in feline diabetes. The definition and diagnostic criteria for prediabetes in cats are not yet established, limiting early intervention studies ^{[6, 3]}. Long-term safety, efficacy, and impact on beta-cell function and remission rates of SGLT2 inhibitors are still under investigation, and robust post-marketing surveillance data are needed.

The role of GLP-1 receptor agonists as monotherapy or for maintaining remission lacks randomized controlled trials in cats ^{[3, 6]}. It is unknown whether repeated mild hypoglycemic episodes in cats lead to impaired counter-regulatory responses and hypoglycemia unawareness, as occurs in humans ^[2]. The contribution of islet amyloidosis to disease progression and the therapeutic potential of anti-amyloid agents remain open research questions ^[7]. The causal relationship between pancreatitis and diabetes requires elucidation, as pancreas inflammation may both trigger and result from diabetes ^{[9, 7]}.

Better screening strategies for subclinical diabetes in high-risk populations are needed to enable earlier preventive interventions ^{[6, 3]}. Genetic risk factors and breed predispositions beyond the Burmese are poorly characterized; larger genome-wide studies are required ^[1]. The optimal dietary macronutrient composition for preventing diabetes in susceptible cats is not yet defined with high-level evidence ^[6]. Finally, robust data on the impact of treatment choices on quality of life for the owner and cat are not yet available ^[6].

Connect with Other Cat Owners

Seeing how other owners handle day-to-day feline diabetes — from insulin injections and glucose curves to choosing the right food — can be genuinely reassuring, and a group full of people living through the same routine is a great place to ask questions a search engine can't really answer.

• Diabetic Cat International

These groups are run by fellow cat owners rather than veterinary professionals, so it's a good idea to confirm any medical advice with your own vet and to double-check the group is still active before jumping in.

❓ Frequently Asked Questions